Moderna MRNA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's free cash flow?
- Moderna (MRNA) reported free cash flow of -$692M in Q1 2026.
- How has Moderna's free cash flow changed year-over-year?
- Moderna's free cash flow increased by 40.0% year-over-year, from -$1.15B to -$692M.
- What is the long-term trend for Moderna's free cash flow?
- Over 2 years (2021 to 2024), Moderna's free cash flow has grown at a -42.8% compound annual growth rate (CAGR), from $13.34B to -$4.36B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.